A detailed history of Brinker Capital Investments, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Brinker Capital Investments, LLC holds 406,825 shares of PFE stock, worth $10.9 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares
406,825
Previous 390,952 4.06%
Holding current value
$10.9 Million
Previous $17.1 Million 21.89%
% of portfolio
0.42%
Previous 0.35%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 06, 2023

BUY
$41.75 - $54.5 $662,697 - $865,078
15,873 Added 4.06%
406,825 $20.9 Million
Q3 2022

Nov 01, 2022

SELL
$43.76 - $53.42 $387,494 - $473,034
-8,855 Reduced 2.21%
390,952 $17.1 Million
Q2 2022

Jul 18, 2022

BUY
$46.53 - $55.17 $339,157 - $402,134
7,289 Added 1.86%
399,807 $21 Million
Q1 2022

May 16, 2022

BUY
$45.75 - $56.69 $3.47 Million - $4.31 Million
75,947 Added 23.99%
392,518 $20.3 Million
Q4 2021

Feb 08, 2022

BUY
$41.32 - $61.25 $780,038 - $1.16 Million
18,878 Added 6.34%
316,571 $18.7 Million
Q3 2021

Nov 08, 2021

BUY
$39.25 - $50.42 $314,431 - $403,914
8,011 Added 2.77%
297,693 $11.7 Million
Q2 2021

Aug 03, 2021

BUY
$35.91 - $40.68 $1.6 Million - $1.81 Million
44,574 Added 18.19%
289,682 $11.3 Million
Q1 2021

May 12, 2021

SELL
$33.49 - $37.77 $708,045 - $798,533
-21,142 Reduced 7.94%
245,108 $8.88 Million
Q4 2020

Feb 16, 2021

SELL
$33.47 - $42.56 $4.84 Million - $6.16 Million
-144,627 Reduced 35.2%
266,250 $9.8 Million
Q3 2020

Dec 03, 2020

BUY
$31.75 - $37.25 $11.9 Million - $13.9 Million
373,414 Added 996.75%
410,877 $15.1 Million
Q2 2020

Aug 12, 2020

BUY
$30.12 - $36.54 $742,819 - $901,149
24,662 Added 192.66%
37,463 $1.23 Million
Q1 2020

May 13, 2020

BUY
$27.03 - $38.62 $36,139 - $51,634
1,337 Added 11.66%
12,801 $418,000
Q4 2019

Feb 06, 2020

BUY
$32.92 - $37.36 $41,742 - $47,372
1,268 Added 12.44%
11,464 $449,000
Q3 2019

Nov 14, 2019

BUY
$32.49 - $42.13 $269,926 - $350,016
8,308 Added 440.04%
10,196 $366,000
Q2 2019

Aug 14, 2019

BUY
$36.98 - $41.52 $31,063 - $34,876
840 Added 80.15%
1,888 $82,000
Q1 2019

May 14, 2019

SELL
$37.5 - $41.2 $25,537 - $28,057
-681 Reduced 39.39%
1,048 $45,000
Q4 2018

Feb 13, 2019

BUY
$38.47 - $43.86 $307 - $350
8 Added 0.46%
1,729 $75,000
Q3 2018

Nov 13, 2018

SELL
$34.47 - $41.81 $1,034 - $1,254
-30 Reduced 1.71%
1,721 $76,000
Q2 2018

Aug 14, 2018

BUY
$32.98 - $35.16 $17,281 - $18,423
524 Added 42.71%
1,751 $64,000
Q1 2018

May 15, 2018

BUY
$31.91 - $37.02 $15,955 - $18,510
500 Added 68.78%
1,227 $44,000
Q4 2017

Feb 12, 2018

SELL
$33.26 - $35.29 $1,330 - $1,411
-40 Reduced 5.22%
727 $26,000
Q3 2017

Nov 14, 2017

BUY
$31.0 - $34.15 $8,122 - $8,947
262 Added 51.88%
767 $27,000
Q2 2017

Aug 08, 2017

BUY
N/A
505
505 $17,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Brinker Capital Investments, LLC Portfolio

Follow Brinker Capital Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brinker Capital Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brinker Capital Investments, LLC with notifications on news.